Results 111 to 120 of about 93,670 (312)

sequana/rnaseq: v0.19.3

<h2>What's Changed</h2> <ul> <li>Fix the default rRNA by @cokelaer in https://github.com/sequana/rnaseq/pull/44</li> </ul> <p><strong>Full Changelog</strong>: https://github.com/sequana/rnaseq/compare/
Thomas Cokelaer, Etienne Kornobis
core   +1 more source

RNAseq-dataset1_20230126

, 2023
RNAseq raw data from Seqcenter (QUO1003393) Illumina sequencing.
Aude Trinquier
core   +1 more source

Monitoring pharmacodynamic and molecular drug targets in liquid biopsy: Exploratory study in liver cancer with modelling of EGFR Receptor engagement

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Liquid biopsy is minimally invasive (compared with tissue biopsy) and has previously been used to generate systems data regarding drug elimination via hepatic enzymes and transporters. This study extends quantitative assessment of systems parameters in liquid biopsy to pharmacodynamic (PD) and disease markers relevant to cancer development
Zubida M. Al‐Majdoub, Armin Sepp, Amin Rostami‐Hodjegan, Brahim Achour   +3 more
wiley   +1 more source

andrewholding/RNASeq-SCN5A: Code supporting publication

RNASeq of SCN5A shRNA knockdown in mouse ...
Andrew Holding
core   +1 more source

RNAseq Profiling Highlights Immune and Barrier Differences among Ichthyoses

Journal of Scientific Innovation in Medicine, 2020
Kunal Malik, Helen He, Ana Pavel, Jianni Wu, Emma Guttman-Yassky   +4 more
doaj   +1 more source

Increased Insulin Action, Glucose Metabolism and Muscle Function in Supervillin‐Knockout and Supervillin‐Mutant Mice

Cytoskeleton, EarlyView.
ABSTRACT We here describe mouse models with complementary homozygous Svil mutations. In skeletal muscle, Svil‐Mut mice express the Svil‐encoded N‐terminus fused to the βgal‐neo gene‐trap tag and lack the highly conserved archvillin C‐terminus; Svil‐KO mice lack expression of all known Svil‐encoded proteins; and Svil‐LoxP mice contain loxP sites for ...
Tara C. Smith, Lauren A. Tauer, Randall H. Friedline, Xiaodi Hu, Duy Tran, Yangyi E. Luo, Nacima Hadjout‐Rabi, Elisabeth R. Barton, Jason K. Kim, Elizabeth J. Luna   +9 more
wiley   +1 more source

RNAseq CavInTh2

, 2019
<p>RNAseq Cav in th2</p ...
Manuel LEBEURRIER
core   +1 more source

Intravenous Lipopolysaccharide Challenge in Healthy Participants Reveals Pharmacodynamic Markers in Blood and Bone Marrow for Early‐Phase Oncology Drug Development

Clinical Pharmacology &Therapeutics, EarlyView.
Demonstrating pharmacological effects in early‐phase oncology clinical trials remains challenging, largely due to the lack of robust pharmacodynamic markers. Lipopolysaccharide (LPS) is used as an immune challenge agent in healthy participants to study drugs for autoimmune conditions.
Igor Radanović, Ingrid Tomljanović, Wieke H. Grievink, Diana R. Pereira, Michelle Osse, Peter van Balen, Maria J. Juachon, Marieke L. de Kam, Lisa Pagan, Manon A.A. Jansen, Matthijs Moerland, Jacobus J. Bosch   +11 more
wiley   +1 more source

RNAseqPS: A Web Tool for Estimating Sample Size and Power for RNAseq Experiment

Cancer Informatics, 2014
Sample size and power determination is the first step in the experimental design of a successful study. Sample size and power calculation is required for applications for National Institutes of Health (NIH) funding.
Yan Guo, Shilin Zhao, Chung-I Li, Quanhu Sheng, Yu Shyr   +4 more
doaj   +1 more source

scRNAseq, bulk-RNAseq and Future Deep Learning RNAseq Analysis: Powerful Prediction Tools in Prostate Cancer Therapy [PDF]

Translational Research in Urology
Most of the present databases in prostate cancer expression studies are in single-cell and bulk RNA sequencing formats. Using these tools, cell-cell interaction could have revealed associated tumor cell profile signatures like RAECs could be determined ...
Mohammad Hosein Karimi
doaj   +1 more source